Zivo Bioscience Stock Forward View
| ZIVO Stock | USD 10.49 1.49 16.56% |
Zivo Stock outlook is based on your current time horizon. Although Zivo Bioscience's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Zivo Bioscience's systematic risk associated with finding meaningful patterns of Zivo Bioscience fundamentals over time.
As of today, The relative strength index (RSI) of Zivo Bioscience's share price is at 51. This usually means that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Zivo Bioscience, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (2.10) | EPS Estimate Next Year (1.08) | Wall Street Target Price 12 | EPS Estimate Current Quarter (0.36) |
Using Zivo Bioscience hype-based prediction, you can estimate the value of Zivo Bioscience from the perspective of Zivo Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Zivo Bioscience on the next trading day is expected to be 11.33 with a mean absolute deviation of 0.82 and the sum of the absolute errors of 50.83. Zivo Bioscience after-hype prediction price | USD 10.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Zivo Bioscience to cross-verify your projections. Zivo Bioscience Additional Predictive Modules
Most predictive techniques to examine Zivo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zivo using various technical indicators. When you analyze Zivo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Zivo Bioscience Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Zivo Bioscience's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2003-12-31 | Previous Quarter 9.8 K | Current Value 57.2 K | Quarterly Volatility 2.1 M |
Zivo Bioscience Naive Prediction Price Forecast For the 1st of February
Given 90 days horizon, the Naive Prediction forecasted value of Zivo Bioscience on the next trading day is expected to be 11.33 with a mean absolute deviation of 0.82, mean absolute percentage error of 1.09, and the sum of the absolute errors of 50.83.Please note that although there have been many attempts to predict Zivo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Zivo Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Zivo Bioscience Stock Forecast Pattern
| Backtest Zivo Bioscience | Zivo Bioscience Price Prediction | Buy or Sell Advice |
Zivo Bioscience Forecasted Value
In the context of forecasting Zivo Bioscience's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Zivo Bioscience's downside and upside margins for the forecasting period are 0.10 and 23.36, respectively. We have considered Zivo Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Zivo Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Zivo Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.0344 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.8199 |
| MAPE | Mean absolute percentage error | 0.0876 |
| SAE | Sum of the absolute errors | 50.832 |
Predictive Modules for Zivo Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zivo Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zivo Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Zivo Bioscience After-Hype Price Density Analysis
As far as predicting the price of Zivo Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zivo Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zivo Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Zivo Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Zivo Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zivo Bioscience's historical news coverage. Zivo Bioscience's after-hype downside and upside margins for the prediction period are 0.51 and 22.31, respectively. We have considered Zivo Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Zivo Bioscience is unstable at this time. Analysis and calculation of next after-hype price of Zivo Bioscience is based on 3 months time horizon.
Zivo Bioscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Zivo Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zivo Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zivo Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 12.03 | 0.21 | 0.03 | 11 Events / Month | 0 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.49 | 10.28 | 2.00 |
|
Zivo Bioscience Hype Timeline
Zivo Bioscience is at this time traded for 10.49. The entity has historical hype elasticity of -0.21, and average elasticity to hype of competition of 0.03. Zivo is anticipated to decline in value after the next headline, with the price expected to drop to 10.28. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.0%, whereas the daily expected return is at this time at 0.21%. The volatility of related hype on Zivo Bioscience is about 9701.61%, with the expected price after the next announcement by competition of 10.52. About 64.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 2.18. Zivo Bioscience had not issued any dividends in recent years. The entity had 1:6 split on the 27th of October 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out Historical Fundamental Analysis of Zivo Bioscience to cross-verify your projections.Zivo Bioscience Related Hype Analysis
Having access to credible news sources related to Zivo Bioscience's direct competition is more important than ever and may enhance your ability to predict Zivo Bioscience's future price movements. Getting to know how Zivo Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zivo Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RLFTY | Relief Therapeutics Holding | 0.00 | 0 per month | 14.29 | 0.03 | 12.57 | (17.40) | 191.19 | |
| CLTEF | Calliditas Therapeutics AB | 0.00 | 0 per month | 0.00 | 0.17 | 28.95 | (38.33) | 58,082 | |
| HBPCF | Helix BioPharma Corp | 1.24 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INNMF | Amplia Therapeutics Limited | 0.00 | 0 per month | 11.67 | 0.1 | 39.24 | (21.00) | 128.67 | |
| RLFTF | Relief Therapeutics Holding | 0.00 | 0 per month | 0.00 | (0.05) | 9.28 | (18.67) | 78.78 | |
| VICP | Vicapsys Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PSYBF | PsyBio Therapeutics Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OTLC | Oncotelic Therapeutics | 0.00 | 0 per month | 0.00 | (0.03) | 12.50 | (11.11) | 47.22 | |
| ACHFF | Arch Biopartners | 0.00 | 0 per month | 2.93 | 0 | 3.33 | (5.26) | 25.55 | |
| AIRDF | Rocket Doctor AI | 0.00 | 0 per month | 0.00 | (0.03) | 9.26 | (7.41) | 24.17 |
Other Forecasting Options for Zivo Bioscience
For every potential investor in Zivo, whether a beginner or expert, Zivo Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zivo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zivo. Basic forecasting techniques help filter out the noise by identifying Zivo Bioscience's price trends.Zivo Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Zivo Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Zivo Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zivo Bioscience shares will generate the highest return on investment. By undertsting and applying Zivo Bioscience stock market strength indicators, traders can identify Zivo Bioscience entry and exit signals to maximize returns.
Zivo Bioscience Risk Indicators
The analysis of Zivo Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zivo Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zivo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.13 | |||
| Semi Deviation | 9.9 | |||
| Standard Deviation | 12.0 | |||
| Variance | 144.08 | |||
| Downside Variance | 176.14 | |||
| Semi Variance | 97.95 | |||
| Expected Short fall | (11.52) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Zivo Bioscience
The number of cover stories for Zivo Bioscience depends on current market conditions and Zivo Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zivo Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zivo Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Zivo Bioscience Short Properties
Zivo Bioscience's future price predictability will typically decrease when Zivo Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zivo Bioscience often depends not only on the future outlook of the potential Zivo Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zivo Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.4 M | |
| Cash And Short Term Investments | 1.5 M |
Check out Historical Fundamental Analysis of Zivo Bioscience to cross-verify your projections. To learn how to invest in Zivo Stock, please use our How to Invest in Zivo Bioscience guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Personal Care Products sector continue expanding? Could Zivo diversify its offerings? Factors like these will boost the valuation of Zivo Bioscience. Anticipated expansion of Zivo directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Zivo Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.18) | Revenue Per Share | Quarterly Revenue Growth 1.083 | Return On Assets | Return On Equity |
Understanding Zivo Bioscience requires distinguishing between market price and book value, where the latter reflects Zivo's accounting equity. The concept of intrinsic value—what Zivo Bioscience's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Zivo Bioscience's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zivo Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zivo Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zivo Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.